RankAlpha logo
Back to Rankings

CGON

CG OncologyC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
CGON vs peer average
60/100
CGON vs. peer average (C vs. D)
Grade spread
C 3 · D 5
Graded peers loaded
Coverage
8 graded
89% of tracked

Peer overview

FGEN is the first available peer comparator.

Company with targeted oncology assets and partnership-driven upside potential; comparable commercialization uncertainty.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerFGEN
CGON
CG Oncology
FGEN
Peer
Grade
C
-
Momentum
81
-
Value
41
-
Sentiment
39
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Unrated
Open Side-by-Side ComparisonCompare all

Grade position vs FGEN

CGON / FGEN
Grade Position
In line
CGON vs. peer average (C vs. D)
60/100
Momentum
81
-
Value
41
-
Sentiment
39
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CGON
1
FGEN
FGEN
-
-
-
2
XENE
Xenon Pharmaceuticals Inc Common
C
60/100
Even
3
BLTE
Belite Bio Inc ADR
D
40/100
+1
4
PTCT
PTC Therapeutics Inc Common
D
40/100
+1
5
LGND
Ligand Pharmaceuticals Inc Common
C
60/100
Even
FGEN is the first peer returned for this comparison set.